Search

Calmare NJ USA

Category

arachnoiditis

CLINICAL TRIAL: Arachnoiditis Nerve Pain Relief

April 12, 2019

2019 CLINICAL TRIAL – DIAGNOSED ARACHNOIDITIS PATIENTS

Study

Calmare Therapy NJ USA (Scrambler Therapy) to Treat Diagnosed Cases of Arachnoiditis to Reduce Chronic Neuropathic Pain Symptoms

Phase

Pilot

What is Arachnoiditis?

Arachnoiditis is a chronic pain disorder caused by the inflammation of the arachnoid membrane and subarachnoid space that surround the nerves of the spinal cord. The inflammation can cause the meninges to adhere to the spinal cord and nerve roots.

Because the nerve roots are affected, symptoms such as numbness, tingling, and burning pain are often felt in the lower back or legs.

Severe cases of arachnoiditis can result in the loss of motor function, loss of bladder and bowel control and even paralysis.

Arachnoiditis can arise from infection, direct spinal injury, and chronic compression of the spinal nerves or invasive spinal surgeries.

Study Conducted by

Dr. Michael J. Cooney
Calmare Therapy NJ USA

Location

Rutherford, NJ (10 miles from New York City)

Study Start Date

May 13 – 24, 2019

Details

Calmare Therapy NJ USA is one of only seven Calmare Certified providers of scrambler therapy, an FDA-cleared, non-invasive, pain-free, drug-free technology to treat patients suffering from several types of long-term, high-intensity pain.

Scope of May 2019 Calmare Study

We are conducting a free, 10-treatment (one 35-minute daily therapy session) clinical trial study for pre-qualified patients suffering from diagnosed Arachnoiditis to determine the efficacy of scrambler therapy as a viable treatment solution for condition-induced neuropathy.

Eligibility Criteria

Pre-approved study patients must be available to undergo a protocol of 10 treatments once per day. There is no charge for the series of 10 treatments.

Travel, daily transportation, meals and accommodations are not covered for this trial

Informed Consent

People who agree to take part in the study are asked to sign an Informed Consent Form. However, signing the form does not mean approved trial participants must stay in the study for the duration. Volunteer participants can leave the study at any time—either before the study starts or at any time during the study or the follow-up period.

The informed consent process continues throughout the study. If new benefits, risks, or side effects are discovered during the study, clinical trial researchers will; inform the participants.

To Apply  |  Contact Us  |  For More Information

To find out more and determine if you qualify for the no-cost study, please contact for a phone consultation or email us at info@calmaretherapynj.com

Dr. Michael Cooney
Clinical Director
Calmare Therapy NJ USA
(201) 933.4440 | calmaretherapynj.com

 

Featured post

Quebec, Australia, Indiana, Louisiana this week

world-mapIn a waiting room survey today, we realized we have patients receiving Calmare Therapy from two countries, Louisiana and Indiana.
There must be some good conversations happening out there!

Blog at WordPress.com.

Up ↑

%d bloggers like this: